Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.64 USD | -1.45% | -1.16% | -15.02% |
05-09 | HilleVax, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-05 | Hillevax Insider Sold Shares Worth $264,467, According to a Recent SEC Filing | MT |
Evolution of the average Target Price on HilleVax, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering HilleVax, Inc.
Stifel Nicolaus | |
HC Wainwright | |
JPMorgan Chase | |
Guggenheim | |
SVB Securities LLC |
EPS Revisions
- Stock Market
- Equities
- HLVX Stock
- Consensus HilleVax, Inc.